Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO

C. William Heise, David Beutler, Adam Bosak, Geoffrey Orme, Akil Loli, Kimberlie Graeme

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Background: Overdose of cardiovascular medications is increasingly associated with morbidity and mortality. We present a case of substantial atenolol, chlorthalidone, and lisinopril overdose treated by multiple modalities with an excellent outcome. Conclusion: Aggressive medical intervention did not provide sufficient hemodynamic stability in this patient with refractory cardiogenic and distributive shock. Impella® percutaneous left ventricular assist device and extracorporeal membrane oxygenation provided support while the effects of the overdose subsided. We present concentrations demonstrating removal of atenolol with continuous venovenous hemodiafiltration. This is the first report of esophagogastroduo denoscopy decontamination of this overdose with a large pill fragment burden.

Original languageEnglish (US)
Pages (from-to)110-114
Number of pages5
JournalJournal of Medical Toxicology
Volume11
Issue number1
DOIs
StatePublished - Mar 1 2015
Externally publishedYes

Keywords

  • Atenolol
  • Beta blocker
  • Continuous venovenous hemodiafiltration atenolol clearance
  • Esophagogastroduodenoscopy decontamination
  • Impella percutaneous left ventricular assist device

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Fingerprint

Dive into the research topics of 'Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO'. Together they form a unique fingerprint.

Cite this